日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial

急性冠脉综合征后使用二十碳五烯酸乙酯:REDUCE-IT 试验

Sayah, Neila; Bhatt, Deepak L; Miller, Michael; Brinton, Eliot A; Jacobson, Terry A; Ketchum, Steven B; Jiao, Lixia; Pineda, Armando Lira; Doyle, Ralph T Jr; Tardif, Jean Claude; Ballantyne, Christie M; Steg, Ph Gabriel

Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT

REDUCE-IT 研究显示,二十碳五烯酸乙酯对伴有和不伴有房颤的患者均有心血管获益。

Olshansky, Brian; Bhatt, Deepak L; Miller, Michael; Steg, Ph Gabriel; Brinton, Eliot A; Jacobson, Terry A; Ketchum, Steven B; Doyle, Ralph T Jr; Juliano, Rebecca A; Jiao, Lixia; Kowey, Peter R; Reiffel, James A; Tardif, Jean-Claude; Ballantyne, Christie M; Chung, Mina K

Effectiveness of icosapent ethyl on first and total cardiovascular events in patients with metabolic syndrome, but without diabetes: REDUCE-IT MetSyn

二十碳五烯酸乙酯对代谢综合征但无糖尿病患者首次和总心血管事件的疗效:REDUCE-IT MetSyn研究

Miller, Michael; Bhatt, Deepak L; Brinton, Eliot A; Jacobson, Terry A; Steg, Philippe Gabriel; Pineda, Armando Lira; Ketchum, Steven B; Doyle, Ralph T Jr; Tardif, Jean-Claude; Ballantyne, Christie M

Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI

使用二十碳五烯酸乙酯治疗可降低既往接受过经皮冠状动脉介入治疗患者的缺血事件发生率:来自 REDUCE-IT PCI 研究的启示

Peterson, Benjamin E; Bhatt, Deepak L; Steg, Ph Gabriel; Miller, Michael; Brinton, Eliot A; Jacobson, Terry A; Ketchum, Steven B; Juliano, Rebecca A; Jiao, Lixia; Doyle, Ralph T Jr; Granowitz, Craig; Gibson, C Michael; Pinto, Duane; Giugliano, Robert P; Budoff, Matthew J; Tardif, Jean-Claude; Verma, Subodh; Ballantyne, Christie M

Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses

二十碳五烯酸乙酯降低血管重建率:来自 REDUCE-IT 血管重建分析的启示

Peterson, Benjamin E; Bhatt, Deepak L; Steg, Ph Gabriel; Miller, Michael; Brinton, Eliot A; Jacobson, Terry A; Ketchum, Steven B; Juliano, Rebecca A; Jiao, Lixia; Doyle, Ralph T Jr; Granowitz, Craig; Gibson, C Michael; Pinto, Duane; Giugliano, Robert P; Budoff, Matthew J; Tardif, Jean-Claude; Verma, Subodh; Ballantyne, Christie M

Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL

二十碳五烯酸乙酯对已确诊心血管疾病或糖尿病患者肾功能各异的益处:REDUCE-IT RENAL

Majithia, Arjun; Bhatt, Deepak L; Friedman, Allon N; Miller, Michael; Steg, Ph Gabriel; Brinton, Eliot A; Jacobson, Terry A; Ketchum, Steven B; Juliano, Rebecca A; Jiao, Lixia; Doyle, Ralph T Jr; Granowitz, Craig; Budoff, Matthew; Preston Mason, R; Tardif, Jean-Claude; Boden, William E; Ballantyne, Christie M

REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final results

REDUCE-IT 中期分析:将预先设定的中期分析数据累积到最终结果。

Olshansky, Brian; Bhatt, Deepak L; Miller, Michael; Steg, Ph Gabriel; Brinton, Eliot A; Jacobson, Terry A; Ketchum, Steven B; Doyle, Ralph T Jr; Juliano, Rebecca A; Jiao, Lixia; Granowitz, Craig; Tardif, Jean-Claude; Mehta, Cyrus; Mukherjee, Rajat; Ballantyne, Christie M; Chung, Mina K

Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies

矿物油:在 REDUCE-IT 和其他临床研究中作为安慰剂的安全性和用途

Olshansky, Brian; Chung, Mina K; Budoff, Matthew J; Philip, Sephy; Jiao, Lixia; Doyle, Ralph T Jr; Copland, Christina; Giaquinto, Alex; Juliano, Rebecca A; Bhatt, Deepak L

Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study

二十碳五烯酸乙酯对接受他汀类药物治疗的高甘油三酯患者脂肪酸谱的影响:一项随机、安慰剂对照的ANCHOR研究

Ballantyne, Christie M; Manku, Mehar S; Bays, Harold E; Philip, Sephy; Granowitz, Craig; Doyle, Ralph T Jr; Juliano, Rebecca A